Opinion

Video

Management of Generalized Myasthenia Gravis in Pediatric Patients

Key Takeaways

  • Diagnosing pediatric gMG is challenging due to its rarity and symptom overlap with other neuromuscular disorders, necessitating careful clinical evaluation.
  • Standard management includes acetylcholinesterase inhibitors, corticosteroids, and immunosuppressants, customized to each patient's needs.
SHOW MORE

Panelists discuss how generalized myasthenia gravis (gMG) presents unique diagnostic challenges in pediatric populations, review current standard-of-care management strategies for children and adolescents, and highlight promising investigational treatments for pediatric gMG.

Video content above is prompted by the following:

  • Generalized MG, although rare, can affect children and adolescents. What are the challenges in diagnosing this patient population?
  • What is the standard of care for management of gMG in the pediatric population?
  • Please highlight some investigational agents for pediatric gMG that you are excited about.
Related Videos
2 experts in this video
Michael Levy, MD, PhD, is featured in this series.
2 experts in this video
2 experts in this video
2 experts in this video
Michael Levy, MD, PhD, is featured in this series.
Michael Levy, MD, PhD, is featured in this series.
Michael Levy, MD, PhD, is featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.